Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHNT.L Regulatory News (HNT)

  • There is currently no data for HNT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

17 Dec 2019 07:00

RNS Number : 0634X
Huntsworth PLC
17 December 2019
 

 

17 December 2019

Trading Update

 

Huntsworth plc ("Huntsworth or the "Group"), the international healthcare and communications group, today issues a trading update for the 11 months to 30 November 2019.

 

·;

Group trading satisfactory, within market expectations

 

·;

Return to growth in Marketing

 

·;

Acquisitions successfully integrated and performing in line with expectations

 

·;

Cash flow strong and gearing expected to fall to c.1.6x at the year-end

 

 

Current Trading

The Group anticipates like-for-like revenue growth of c. 3% for the full year, with a small impact on margin as a result of investments in property and talent, and expects to report headline profit before tax within current market expectations* for the year to 31 December 2019.

As expected, the Marketing division saw an acceleration of growth over the second half of the year, although client-led project deferrals and product closures limited the level of growth to c. 3% across the half. Project wins were good, and the pipeline of opportunities is strong, especially in multi-service requirements where the additional capabilities of acquired businesses can be deployed, indicating further improvement and good prospects for 2020.

There was further good growth in the Medical division leading to c. 8% like-for-like growth for the full year. The Immersive division performed well against very strong comparatives and has secured a number of new mandates which indicate good growth prospects for 2020, although the cost of securing these mandates impacted profits.

The Communications division saw an acceleration of growth in the second half and will achieve full year revenue growth of c. 2% for the first time in several years.

 

Financial Position

The Group remains in a strong financial position, operating well within its £130m facility, and expects year end leverage to be c. 1.6x net debt to pro forma EBITDA**.

  

Outlook

The Group remains focused on delivering superior growth led by its healthcare agencies and recent acquisitions continue to complement this. Despite some currency headwinds as a result of the strengthening in sterling, management is confident about the Group's future trading and expects continued good growth across all of its businesses in 2020.

 

* Market expectations of Headline PBT range from £38.5m to £41.0m

** Pro forma EBITDA takes into account a full year's contribution from acquisitions made during 2019. Leverage is on a pre-IFRS 16 basis.

 

 

 Enquiries

 

 

Citigate Dewe Rogerson

020 7638 9571

Angharad Couch

Nick Reading

Elizabeth Kittle

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTGGGGPPUPBGBQ
Date   Source Headline
6th Mar 20195:09 pmRNSHolding(s) in Company
6th Mar 20197:00 amRNSDirectorate Change
5th Mar 20197:00 amRNSPreliminary Results for year end 31 December 2018
4th Feb 20195:15 pmRNSHolding(s) in Company
28th Jan 20195:45 pmRNSHolding(s) in Company
21st Jan 20197:00 amRNSNotice of Results
11th Jan 20194:01 pmRNSHolding(s) in Company
7th Jan 20195:53 pmRNSStandard form for notification of major holdings
7th Jan 20195:14 pmRNSStandard form for notification of major holdings
7th Jan 20193:08 pmRNSStandard form for notification of major holdings
19th Dec 201810:00 amRNSDirectorate Change and Appointment of Chairman
17th Dec 201812:07 pmRNSSecond Price Monitoring Extn
17th Dec 201812:02 pmRNSPrice Monitoring Extension
13th Dec 20184:27 pmRNSHoldings in Company
12th Dec 20187:00 amRNSTrading Update
4th Dec 20186:04 pmRNSHolding(s) in Company
3rd Dec 20187:00 amRNSTotal Voting Rights and Capital
12th Nov 20181:25 pmRNSDirector/PDMR Shareholding
8th Nov 20182:23 pmRNSDirector Declaration
6th Nov 20183:23 pmRNSDirector/PDMR Shareholding
5th Nov 20187:00 amRNSAdditional Listing
1st Nov 20187:00 amRNSNotification of Total Voting Rights and Capital
29th Oct 20184:35 pmRNSPrice Monitoring Extension
10th Oct 20184:56 pmRNSHolding in Company
9th Oct 20185:15 pmRNSDirector/PDMR Shareholding
8th Oct 20184:56 pmRNSTransfer of Treasury Shares
4th Oct 20184:31 pmRNSNotification of Major Holdings
4th Oct 20183:31 pmRNSScrip Dividend Alternative
4th Oct 20187:00 amRNSCompletion of Acquisition
3rd Oct 20184:57 pmRNSNotification of Major Holdings
3rd Oct 20184:41 pmRNSStandard form for notification of major holdings
3rd Oct 201810:43 amRNSNotification of Major Holdings
1st Oct 20185:22 pmRNSNotification of Major Holdings
28th Sep 201810:00 amRNSStandard form for notification of major holdings
28th Sep 20187:00 amRNSResults of placing
27th Sep 20184:56 pmRNSProposed acquisition of Navience Healthcare
26th Sep 20183:13 pmRNSStandard form for notification of major holdings
10th Aug 20185:01 pmRNSHolding in Company
10th Aug 20184:59 pmRNSHolding in Company
1st Aug 20187:00 amRNSTotal Voting Rights and Capital
24th Jul 20187:00 amRNSInterim results for the six months to 30 June 2018
17th Jul 20187:00 amRNSAcquisition of Giant Creative Strategy LLC
13th Jul 20184:11 pmRNSHolding in Company
12th Jul 201812:38 pmRNSHolding in Company
11th Jul 20183:00 pmRNSHolding in Company
5th Jul 20181:37 pmRNSHolding in Company
5th Jul 201810:07 amRNSDirector/PDMR Shareholding
4th Jul 20187:00 amRNSAdditional Listing
3rd Jul 201810:05 amRNSHolding in Company
3rd Jul 201810:04 amRNSHolding in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.